[EN] BETA-HYDROXYETHYLAMINES FOR USE IN THE TREATMENT OR PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASES<br/>[FR] BÊTA-HYDROXYÉTHYLAMINES POUR UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION DES STÉATOSES HÉPATIQUES NON ALCOOLIQUES
申请人:ATROGI AB
公开号:WO2019053428A1
公开(公告)日:2019-03-21
There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a non-alcoholic fatty liver disease (NAFLD), such as non-alcoholic steatohepatitis (NASH), wherein X, R1, R2, R3 and n have meanings as provided in the description.
本文提供了一种化合物(I)或其药用可接受盐,用于治疗非酒精性脂肪肝病(NAFLD),如非酒精性脂肪性肝炎(NASH),其中X、R1、R2、R3和n的含义如描述中所提供。